CN1433314B - 抗菌组合物及其使用方法 - Google Patents

抗菌组合物及其使用方法 Download PDF

Info

Publication number
CN1433314B
CN1433314B CN008187452A CN00818745A CN1433314B CN 1433314 B CN1433314 B CN 1433314B CN 008187452 A CN008187452 A CN 008187452A CN 00818745 A CN00818745 A CN 00818745A CN 1433314 B CN1433314 B CN 1433314B
Authority
CN
China
Prior art keywords
volume
emulsion
compositions
oil
bctp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN008187452A
Other languages
English (en)
Chinese (zh)
Other versions
CN1433314A (zh
Inventor
J·R·小贝克
T·哈姆达
A·史
M·安德尔杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan Ann Arbor
Original Assignee
University of Michigan Ann Arbor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan Ann Arbor filed Critical University of Michigan Ann Arbor
Publication of CN1433314A publication Critical patent/CN1433314A/zh
Application granted granted Critical
Publication of CN1433314B publication Critical patent/CN1433314B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN008187452A 1999-12-30 2000-12-29 抗菌组合物及其使用方法 Expired - Lifetime CN1433314B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US47486699A 1999-12-30 1999-12-30
US09/474,866 1999-12-30
US09/561,111 2000-04-28
US09/561,111 US6506803B1 (en) 1999-04-28 2000-04-28 Methods of preventing and treating microbial infections
PCT/US2000/035651 WO2001049296A1 (en) 1999-12-30 2000-12-29 Antimicrobial compositions and methods of use

Publications (2)

Publication Number Publication Date
CN1433314A CN1433314A (zh) 2003-07-30
CN1433314B true CN1433314B (zh) 2011-08-31

Family

ID=27044598

Family Applications (1)

Application Number Title Priority Date Filing Date
CN008187452A Expired - Lifetime CN1433314B (zh) 1999-12-30 2000-12-29 抗菌组合物及其使用方法

Country Status (11)

Country Link
US (1) US6506803B1 (OSRAM)
EP (2) EP2364709B1 (OSRAM)
JP (2) JP5013495B2 (OSRAM)
CN (1) CN1433314B (OSRAM)
AU (1) AU2609901A (OSRAM)
BR (1) BR0016796A (OSRAM)
CA (1) CA2395678C (OSRAM)
DK (1) DK1242095T3 (OSRAM)
ES (1) ES2425971T3 (OSRAM)
MX (1) MXPA02006564A (OSRAM)
WO (1) WO2001049296A1 (OSRAM)

Families Citing this family (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) * 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US8232320B2 (en) * 1999-04-28 2012-07-31 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
TR200200776T2 (tr) * 1999-09-24 2002-06-21 Smithkline Beecham Biologicals S.A. Burun içi grip virüsü aşısı.
US6794352B2 (en) 2000-06-12 2004-09-21 Jeffrey S. Svendsen Cleaning towel having a color identifying label and sanitizer release polymer composition
EP2545937A1 (en) * 2001-06-05 2013-01-16 The Regents Of The University Of Michigan Nanoemulsion vaccines
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
WO2003020024A2 (en) * 2001-08-28 2003-03-13 Eden Research Plc Treatment and prevention of infections in plants
US6667290B2 (en) 2001-09-19 2003-12-23 Jeffrey S. Svendsen Substrate treated with a binder comprising positive or neutral ions
US7745686B2 (en) 2001-11-02 2010-06-29 Playtex Products, Inc. Catamenial device
US7799968B2 (en) * 2001-12-21 2010-09-21 Kimberly-Clark Worldwide, Inc. Sponge-like pad comprising paper layers and method of manufacture
US20030175318A1 (en) * 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
DE60215558T2 (de) * 2002-04-17 2007-08-02 Agribiotec S.R.L. Benutzung von pflanzlichem öl als adjuvantien für fungizide, bakterizide, insektizide oder herbizide substanzen
GB0213097D0 (en) 2002-06-07 2002-07-17 Autoglym Improvements in or relating to organic matter
US7994079B2 (en) * 2002-12-17 2011-08-09 Kimberly-Clark Worldwide, Inc. Meltblown scrubbing product
US20040111817A1 (en) * 2002-12-17 2004-06-17 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
BRPI0408099B1 (pt) 2003-03-05 2014-04-08 Byocoat Entpr Inc Solução antimicrobiana e processo
WO2005002337A1 (en) * 2003-04-02 2005-01-13 Virtual Drug Development, Inc. Disinfectant compositions and methods
US20040204496A1 (en) * 2003-04-11 2004-10-14 Ammon Daniel M. Disinfecting solutions effective against bacterial endospores
EP1633322A2 (en) * 2003-06-04 2006-03-15 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US7348097B2 (en) * 2003-06-17 2008-03-25 Medtronic, Inc. Insulative feed through assembly for electrochemical devices
EP1648412B1 (en) * 2003-07-07 2007-11-14 Nares AB Microemulsions and its use for preventing airway diseases
US8211448B2 (en) * 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
CA2545117A1 (en) * 2003-11-07 2005-05-26 Viratox, L.L.C. Virucidal activities of a combination of cetylpyridinium chloride and citric acid
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050130536A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US20050129897A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US20050136772A1 (en) * 2003-12-23 2005-06-23 Kimberly-Clark Worldwide, Inc. Composite structures containing tissue webs and other nonwovens
PL1711058T3 (pl) * 2004-01-23 2022-02-07 Eden Research Plc Sposoby zabijania nicieni obejmujące aplikację składnika terpenowego
US7707931B2 (en) 2004-04-06 2010-05-04 West Liberty Foods, L.L.C. Clean room food processing systems, methods and structures
PT2338332E (pt) * 2004-05-20 2014-05-15 Eden Research Plc Partícula oca de glucano ou partícula de parede celular que encapsula um componente de terpeno
US20050260138A1 (en) * 2004-05-21 2005-11-24 Virgil Flanigan Producton and use of a gaseous vapor disinfectant
NZ534007A (en) 2004-07-09 2007-06-29 Horticulture & Food Res Inst Fungicidal composition comprising anhydrous milk fat (AMF) and soybean oil for the treatment of Powdery Mildew
US20060135026A1 (en) * 2004-12-22 2006-06-22 Kimberly-Clark Worldwide, Inc. Composite cleaning products having shape resilient layer
US20060204469A1 (en) * 2005-03-09 2006-09-14 Eric Spengler Stable mixed emulsions
EP1871349A1 (en) * 2005-04-11 2008-01-02 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
US20060292248A1 (en) * 2005-06-20 2006-12-28 Bio-Germ Protection, Llc Biological attack protection kit and method
US20070015738A1 (en) * 2005-07-15 2007-01-18 Walker Stephen G Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
WO2008051186A2 (en) 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
WO2007030104A1 (en) * 2005-09-03 2007-03-15 Byocoat Enterprises, Inc. Antimicrobial solutions and process related thereto
WO2007040598A2 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
WO2007063267A1 (en) 2005-11-30 2007-06-07 Eden Research Plc Terpene-containing compositions and methods of making and using them
KR101478012B1 (ko) 2005-11-30 2015-01-02 에덴 리서치 피엘씨 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
TWI458495B (zh) * 2006-03-23 2014-11-01 Glaxosmithkline Llc 牙齒器具清潔劑
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US20080038295A1 (en) * 2006-04-13 2008-02-14 Regents Of The University Of Michigan Compositions and methods for orthopox virus vaccination
US9839685B2 (en) * 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
US8741954B2 (en) * 2007-02-21 2014-06-03 Viratox, L.L.C. Synergistic enhancement of calcium propionate
CN101032507B (zh) * 2007-04-06 2010-09-29 西北农林科技大学 一种红霉素纳米乳抗菌药物及其制备方法
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2280690A2 (en) * 2008-04-18 2011-02-09 Nanobio Corporation Methods for treating herpes virus infections
EP3023107A1 (en) 2008-04-21 2016-05-25 Nanobio Corporation Nanoemulsion influenza vaccine
WO2009132343A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating onchomycosis
CA2722445A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
CA2725381A1 (en) * 2008-05-23 2010-03-25 The Regents Of The University Of Michigan Nanoemulsion adjuvants
US9415006B2 (en) * 2008-05-23 2016-08-16 The Regents Of The University Of Michigan Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
FR2933104B1 (fr) * 2008-06-26 2015-10-09 Biomerieux Sa Milieu de culture comportant un compose inhibiteur ou retardateur de germination de spores
RU2371328C1 (ru) * 2008-07-01 2009-10-27 Государственное образовательное учреждение высшего профессионального образования Иркутский государственный университет Способ временной обратимой консервации артефактов
WO2010036945A2 (en) * 2008-09-26 2010-04-01 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
CN102202672A (zh) 2008-10-10 2011-09-28 达拉生物科学公司 使用穗霉素衍生物治疗或预防疼痛的方法
US9974844B2 (en) 2008-11-17 2018-05-22 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
WO2010061330A1 (en) * 2008-11-26 2010-06-03 Viroblock S.A. Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
EP2391342A2 (en) * 2009-01-28 2011-12-07 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
WO2010132833A1 (en) 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
NZ597182A (en) 2009-05-22 2014-07-25 Genocea Biosciences Inc Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
ES2566646T3 (es) * 2009-06-16 2016-04-14 The Regents Of The University Of Michigan Vacunas en nanoemulsión
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US20110200683A1 (en) * 2010-02-16 2011-08-18 Piper Medical, Inc Hydrogen peroxide solution producing first aid substance, packaging, and treatment
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
US20110229512A1 (en) * 2010-03-19 2011-09-22 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating urinary tract infections
MX349265B (es) 2010-05-20 2017-07-20 Ecolab Usa Inc Composiciones antimicrobianas liquidas de baja formacion de espuma, modificadas reologicamente, y sus metodos de uso.
JP2014520805A (ja) 2011-07-06 2014-08-25 ナノバイオ コーポレーション ヒト呼吸器合胞体ウイルスワクチン
CA2845872C (en) 2011-08-22 2023-03-28 Nanobio Corporation Herpes simplex virus nanoemulsion vaccine
CN104093421A (zh) 2011-09-09 2014-10-08 纳诺碧欧公司 纳米乳液呼吸道合胞病毒(rsv)亚单位疫苗
WO2013078299A1 (en) 2011-11-23 2013-05-30 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CN102526139A (zh) * 2012-02-23 2012-07-04 华子昂 一种人工阴道液及其制备方法
FR2997304B1 (fr) * 2012-10-26 2017-07-07 Isp Investments Inc Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CN103830726A (zh) * 2012-11-23 2014-06-04 魏维 抗微生物有机纳米组合物及其制备方法
KR20140141857A (ko) * 2013-05-31 2014-12-11 한국생명공학연구원 패실로마이세스 속 균주를 이용한 생물 농약 제조방법
EP3204039B1 (en) 2014-10-10 2022-06-08 The Regents Of The University Of Michigan Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
WO2016179112A1 (en) 2015-05-01 2016-11-10 Precision Biosciences, Inc. Precise deletion of chromoscomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases
WO2017007835A1 (en) 2015-07-07 2017-01-12 Nanobio Corporation Methods and compositions for nanoemulsion vaccine formulations
WO2017044649A1 (en) 2015-09-08 2017-03-16 Precision Biosciences, Inc. Treatment of retinitis pigmentosa using engineered meganucleases
EP3756682B8 (en) 2015-10-05 2022-04-27 Precision Biosciences, Inc. Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene
CA3001008A1 (en) 2015-10-05 2017-04-13 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
WO2017112859A1 (en) 2015-12-23 2017-06-29 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene
GB2570382B (en) 2016-04-27 2020-07-29 Univ Puerto Rico 1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases
CA3022801A1 (en) 2016-05-03 2017-11-09 Precision Biosciences, Inc. Engineered nucleases useful for treatment of hemophilia a
US12076397B2 (en) 2016-05-10 2024-09-03 The Regents Of The University Of Michigan Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
WO2017201390A1 (en) 2016-05-19 2017-11-23 The Regents Of The University Of Michigan Novel adjuvant compositions
JP6897031B2 (ja) * 2016-09-01 2021-06-30 住友ベークライト株式会社 防カビ剤、防カビ樹脂フィルム、防カビ積層フィルム及び防カビ包装体
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
EP3523326B1 (en) 2016-10-04 2020-06-03 Precision Biosciences, Inc. Co-stimulatory domains for use in genetically-modified cells
US10662416B2 (en) 2016-10-14 2020-05-26 Precision Biosciences, Inc. Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
WO2018073393A2 (en) 2016-10-19 2018-04-26 Cellectis Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
IL301059B1 (en) 2017-04-21 2025-12-01 Prec Biosciences Inc Engineered meganucleases specific for recognition sequences in the pcsk9 gene
US20200190541A1 (en) 2017-04-28 2020-06-18 Precision Biosciences, Inc. Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells
AU2018266698A1 (en) 2017-05-08 2019-11-28 Precision Biosciences, Inc. Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
CA3068465A1 (en) 2017-06-30 2019-01-03 Precision Biosciences, Inc. Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
JP7138702B2 (ja) 2017-09-22 2022-09-16 ベクトン・ディキンソン・アンド・カンパニー カテーテルロック溶液としての使用のための４％クエン酸三ナトリウム溶液
US20200239544A1 (en) 2017-10-03 2020-07-30 Precision Biosciences, Inc. Modified epidermal growth factor receptor peptides for use in genetically-modified cells
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
WO2019089913A1 (en) 2017-11-01 2019-05-09 Precision Biosciences, Inc. Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
ES2955408T3 (es) 2018-04-12 2023-11-30 Prec Biosciences Inc Nucleasas modificadas genéticamente optimizadas que tienen especificidad para el gen de la región constante alfa del receptor de linfocitos t humanos
TW201945388A (zh) 2018-04-12 2019-12-01 美商精密生物科學公司 對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶
US11369578B2 (en) 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
CA3119836A1 (en) 2018-11-15 2020-05-22 Bluewillow Biologics, Inc. Nanoemulsion compositions having enhanced permeability
WO2020132659A1 (en) 2018-12-21 2020-06-25 Precision Biosciences, Inc. Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
CN109845757A (zh) * 2019-03-15 2019-06-07 威海市农业科学院 果园用病虫害铲除剂及其制备方法、使用方法
JP7286796B2 (ja) 2019-04-03 2023-06-05 プレシジョン バイオサイエンシズ，インク． マイクロｒｎａ適合ｓｈｒｎａ（ｓｈｒｎａｍｉｒ）を含む遺伝子改変免疫細胞
US20220273715A1 (en) 2019-07-25 2022-09-01 Precision Biosciences, Inc. Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
JP2022544825A (ja) 2019-08-20 2022-10-21 プレシジョン バイオサイエンシズ，インク． 細胞免疫療法のためのリンパ球枯渇投与レジメン
JP7101375B2 (ja) * 2019-10-17 2022-07-15 タマ化学工業株式会社 除菌組成物及びそれを用いる細菌芽胞の除菌方法
US20220411479A1 (en) 2019-10-30 2022-12-29 Precision Biosciences, Inc. Cd20 chimeric antigen receptors and methods of use for immunotherapy
WO2021113765A1 (en) 2019-12-06 2021-06-10 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
US20230036065A1 (en) 2019-12-06 2023-02-02 Precision Biosciences, Inc. Methods for cancer immunotherapy
CN111110631A (zh) * 2020-03-20 2020-05-08 苏国霞 一种高效广谱的抗菌纳米乳及其制备方法
WO2021231259A1 (en) 2020-05-11 2021-11-18 Precision Biosciences, Inc. Self-limiting viral vectors encoding nucleases
US20230193230A1 (en) 2020-05-12 2023-06-22 Precision Biosciences, Inc. Treatment of retinitis pigmentosa using improved engineered meganucleases
US20260028412A1 (en) 2020-08-10 2026-01-29 Precision Biosciences, Inc. Antibodies and fragments specific for b-cell maturation antigen and uses thereof
US20240011003A1 (en) 2020-08-21 2024-01-11 Precision Biosciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
JP2022060747A (ja) * 2020-10-05 2022-04-15 サンスター株式会社 抗ウイルス用口腔用組成物
KR20250099412A (ko) 2020-11-12 2025-07-01 프리시젼 바이오사이언시스 인코포레이티드 디스트로핀 유전자 내의 인식 서열에 대해 특이성을 갖는 조작된 메가뉴클레아제
WO2022150616A1 (en) 2021-01-08 2022-07-14 Precision Biosciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
US20250127811A1 (en) 2021-01-28 2025-04-24 Precision Biosciences, Inc. Modulation of tgf beta signaling in genetically-modified eukaryotic cells
CA3173051A1 (en) 2021-04-22 2022-10-22 Precision Biosciences, Inc. Engineered meganucleases that target human mitochondrial genomes
KR20240010467A (ko) 2021-04-22 2024-01-23 프리시젼 바이오사이언시스 인코포레이티드 인간 미토콘드리아 게놈을 표적화하는 조작된 메가뉴클레아제
US20240408235A1 (en) 2021-10-19 2024-12-12 Precision Biosciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
US20250228973A1 (en) 2021-10-19 2025-07-17 Precision Biosciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
WO2023081767A1 (en) 2021-11-05 2023-05-11 Precision Biosciences, Inc. Methods for immunotherapy
IL321936A (en) 2023-01-05 2025-09-01 Prec Biosciences Inc Optimized engineered meganucleases with specificity for the human T-cell receptor alpha constant region gene
AU2024255934A1 (en) 2023-04-14 2025-11-20 Precision Biosciences, Inc. Muscle-specific expression cassettes
WO2024216116A1 (en) 2023-04-14 2024-10-17 Precision Biosciences, Inc. Muscle-specific expression cassettes
WO2025101946A1 (en) 2023-11-08 2025-05-15 Precision Biosciences, Inc. Polypeptide linkers for use in engineered meganucleases
WO2025233894A1 (en) 2024-05-09 2025-11-13 University Of Miami Engineered meganucleases that target human mitochondrial genomes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321579A (en) * 1971-04-02 1973-06-27 Lepetit Spa Oil-in-water cosmetic emulsion
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
CN1159158A (zh) * 1994-05-20 1997-09-10 诺瓦瓦克斯有限公司 抗菌水包油乳液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451267A (en) * 1982-09-29 1984-05-29 The United States Of America As Represented By The Secretary Of Agriculture Microemulsions from vegetable oil and aqueous alcohol with trialkylamine surfactant as alternative fuel for diesel engines
US4599088A (en) * 1984-08-30 1986-07-08 Texaco Inc. Clear stable gasoline-alcohol-water motor fuel composition
JPS63221835A (ja) * 1987-03-09 1988-09-14 Lion Corp 安定な水中油型エマルジヨンの製造方法
JP2506125B2 (ja) * 1987-10-06 1996-06-12 雄二 加藤 殺菌及び柔軟剤組成物
US4895452A (en) 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5103497A (en) 1989-11-14 1992-04-07 Hicks John W Flying spot endoscope
US5108660A (en) 1990-01-29 1992-04-28 The Procter & Gamble Company Hard surface liquid detergent compositions containing hydrocarbyl amidoalkylenesulfobetaine
US5709879A (en) 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
JPH05124910A (ja) * 1991-10-31 1993-05-21 Takeshi Uchibori 殺菌消毒液及びこれを用いる殺菌消毒材
JPH06279268A (ja) * 1993-01-27 1994-10-04 Takeda Chem Ind Ltd 消毒殺菌剤およびこれを含有するエアゾール組成物
JP3487359B2 (ja) * 1993-09-30 2004-01-19 株式会社資生堂 殺菌洗浄用組成物
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5368837A (en) 1994-04-14 1994-11-29 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
US5547677A (en) 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
US6348187B1 (en) 1996-01-24 2002-02-19 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
US5662957A (en) 1996-05-03 1997-09-02 Novavax, Inc. Oil containing lipid vesicles with marine applications
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5700679A (en) 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
FR2750329B1 (fr) * 1996-06-28 1998-08-14 Oreal Emulsion huile-dans-eau ultrafine gelifiee et stabilisee par un poly(acide 2 -acrylamido 2 -methylpropane sulfonique) reticule et neutralise a au moins 90 %, procede de preparation et applications
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
US6361787B1 (en) 1998-05-27 2002-03-26 The Clorox Company Enhanced antimicrobial composition
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321579A (en) * 1971-04-02 1973-06-27 Lepetit Spa Oil-in-water cosmetic emulsion
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
CN1159158A (zh) * 1994-05-20 1997-09-10 诺瓦瓦克斯有限公司 抗菌水包油乳液

Also Published As

Publication number Publication date
JP5013495B2 (ja) 2012-08-29
JP2003519184A (ja) 2003-06-17
EP1242095A1 (en) 2002-09-25
CA2395678C (en) 2012-06-26
US6506803B1 (en) 2003-01-14
JP2012136533A (ja) 2012-07-19
DK1242095T3 (da) 2013-08-12
CN1433314A (zh) 2003-07-30
CA2395678A1 (en) 2001-07-12
EP2364709B1 (en) 2012-11-28
EP2364709A1 (en) 2011-09-14
EP1242095B1 (en) 2013-05-29
AU2609901A (en) 2001-07-16
WO2001049296A1 (en) 2001-07-12
BR0016796A (pt) 2003-06-10
MXPA02006564A (es) 2004-07-30
ES2425971T3 (es) 2013-10-18
EP1242095A4 (en) 2005-03-16
HK1055897A1 (en) 2004-01-30

Similar Documents

Publication Publication Date Title
CN1433314B (zh) 抗菌组合物及其使用方法
US7767216B2 (en) Antimicrobial compositions and methods of use
AU2005201276B2 (en) Antimicrobial nanoemulsion compositions and methods
US6559189B2 (en) Non-toxic antimicrobial compositions and methods of use
US8232320B2 (en) Antimicrobial nanoemulsion compositions and methods
US7655252B2 (en) Antimicrobial nanoemulsion compositions and methods
AU2004273779B2 (en) Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
AU2002350587A1 (en) Antimicrobial nanoemulsion compositions and methods
AU2016296150A1 (en) Antimicrobial compositions and formulations releasing hydrogen peroxide
US20100120915A1 (en) Antimicrobials and related methods
WO2005030172A1 (en) Antimicrobial nanoemulsion compositions and methods
HK1055897B (en) Antimicrobial compositions and methods of use
JP2010209109A (ja) 抗微生物ナノエマルジョンの組成物および方法
AU2003203452A8 (en) Topical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CI01 Publication of corrected invention patent application
CI01 Publication of corrected invention patent application

Correction item: Priority

Correct: 1)09/474,866;19991230;US|2)09/561,111;20000428;US

Number: 35

Volume: 27

CI02 Correction of invention patent application
CI02 Correction of invention patent application

Correction item: Priority

Correct: 1)09/474,866;19991230;US|2)09/561,111;20000428;US

Number: 35

Page: The title page

Volume: 27

ERR Gazette correction

Free format text: CORRECT: PRIORITY; FROM: NONE TO: 1)09/474,866;19991230;US 2)09/561,111;20000428;US

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1055897

Country of ref document: HK

CX01 Expiry of patent term

Granted publication date: 20110831

CX01 Expiry of patent term